Kaifa Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kaifa Tang has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
Bangwei Che
Department of Urology and Andrology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
23 shared publicationsJun He
Guizhou Medical University
11 shared publicationsShenghan Xu
Affiliated Hospital of Guizhou Medical University
10 shared publicationsWei Li
Department of Urology and Andrology, the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China
9 shared publicationsWenjun Zhang
Department of Urology and Andrology, the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China
9 shared publicationsYi Mu
Affiliated Hospital of Guizhou Medical University
9 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1999318
Integrated multi-omics analysis supports a causal association of chronic obstructive pulmonary disease with benign prostatic hyperplasia and interactions between VCAN-high fibroblasts and macrophages in hyperplastic prostate tissue
Background: Chronic obstructive pulmonary disease (COPD) and benign prostatic hyperplasia (BPH) are common among middle-aged and older men and can coexist clinically. However, the direction of causality and the underlying biological links between them remain unclear. Methods: The population-level association between COPD and BPH was evaluated using data from the National Health and Nutrition Examination Survey (NHANES), and Mendelian randomization (MR) was used to assess potential causal directions and immune-related genetic features. We integrated transcriptomic analyses of both diseases and used differential expression, functional enrichment, co-expression network analysis, and machine learning to characterize disease-associated transcriptional profiles and identify shared candidate genes. Single-cell and spatial transcriptomic analyses were further used to determine the cellular localization of the key candidate, characterize associated functional states, and assess potential cell-cell interactions. Finally, core mechanisms were validated through co-culture, immunofluorescence, and other experiments. Results: NHANES analysis showed that COPD was significantly associated with prevalent BPH. MR supported a causal effect of COPD on BPH risk; this finding remained stable in multivariable analyses, whereas reverse MR showed no clear effect. Immunogenetic analyses suggested partially overlapping immune features in the two diseases, and transcriptomic findings further converged on immune-inflammatory and extracellular matrix (ECM) remodeling-related changes. VCAN was identified as a shared key candidate gene that was consistently upregulated in both diseases and validated in external cohorts. Single-cell analysis showed that VCAN was expressed predominantly in prostatic fibroblasts; high VCAN expression was associated with higher inflammatory response and ECM remodeling scores and with predicted communication and spatial associations with macrophages. In vitro , co-culture with M1-like macrophages enhanced VCAN expression, proliferation, and ECM remodeling-related phenotypes in WPMY-1 cells, whereas VCAN silencing attenuated these changes. Conclusions: This study provides evidence that COPD increases BPH risk and suggests that the two diseases have partially shared immune-inflammatory and ECM remodeling features. VCAN may contribute to prostatic stromal cell proliferation and ECM remodeling induced by macrophage-associated inflammation.
- 11 November 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1999318
Open AccessIntegrated multi-omics analysis supports a causal association of chronic obstructive pulmonary disease with benign prostatic hyperplasia and interactions between VCAN-high fibroblasts and macrophages in hyperplastic prostate tissue
Background: Chronic obstructive pulmonary disease (COPD) and benign prostatic hyperplasia (BPH) are common among middle-aged and older men and can coexist clinically. However, the direction of causality and the underlying biological links between them remain unclear. Methods: The population-level association between COPD and BPH was evaluated using data from the National Health and Nutrition Examination Survey (NHANES), and Mendelian randomization (MR) was used to assess potential causal directions and immune-related genetic features. We integrated transcriptomic analyses of both diseases and used differential expression, functional enrichment, co-expression network analysis, and machine learning to characterize disease-associated transcriptional profiles and identify shared candidate genes. Single-cell and spatial transcriptomic analyses were further used to determine the cellular localization of the key candidate, characterize associated functional states, and assess potential cell-cell interactions. Finally, core mechanisms were validated through co-culture, immunofluorescence, and other experiments. Results: NHANES analysis showed that COPD was significantly associated with prevalent BPH. MR supported a causal effect of COPD on BPH risk; this finding remained stable in multivariable analyses, whereas reverse MR showed no clear effect. Immunogenetic analyses suggested partially overlapping immune features in the two diseases, and transcriptomic findings further converged on immune-inflammatory and extracellular matrix (ECM) remodeling-related changes. VCAN was identified as a shared key candidate gene that was consistently upregulated in both diseases and validated in external cohorts. Single-cell analysis showed that VCAN was expressed predominantly in prostatic fibroblasts; high VCAN expression was associated with higher inflammatory response and ECM remodeling scores and with predicted communication and spatial associations with macrophages. In vitro , co-culture with M1-like macrophages enhanced VCAN expression, proliferation, and ECM remodeling-related phenotypes in WPMY-1 cells, whereas VCAN silencing attenuated these changes. Conclusions: This study provides evidence that COPD increases BPH risk and suggests that the two diseases have partially shared immune-inflammatory and ECM remodeling features. VCAN may contribute to prostatic stromal cell proliferation and ECM remodeling induced by macrophage-associated inflammation.
- Open Access
- 2 October 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1918612
Mixed epithelial and stromal tumor of the kidney with prominent peritumoral adipose tissue: a case report radiologically mimicking angiomyolipoma with epithelial cysts
Mixed epithelial and stromal tumor of the kidney (MEST) is a rare renal neoplasm with biphasic differentiation comprising epithelial and stromal components. It typically appears as a mixed cystic-solid mass on imaging, and the prognosis is favorable in the vast majority of cases. We report a case of MEST with a prominent fat component on imaging: a 54-year-old woman was admitted with a 1-month history of left flank distension and pain. Contrast-enhanced computed tomography (CT) showed a mixed cystic-solid mass at the lower pole of the left kidney, with a prominent low-attenuation fat-density area surrounding the mass. Preoperatively, the lesion was considered an unusual angiomyolipoma with epithelial cysts (AMLEC). Because the lesion was small, located at the lower pole, and relatively well circumscribed, the patient underwent laparoscopic left partial nephrectomy. Postoperative histopathologic examination confirmed that the left renal mass was benign; however, immunohistochemistry (IHC) demonstrated positivity for EMA and PCK in the epithelial component and for PR and ER in the stromal component, supporting a diagnosis of MEST. The adipose tissue submitted separately with the tumor was located around the tumor and could not be definitively confirmed as an intratumoral component. This case demonstrates that MEST may also exhibit prominent adipose tissue on imaging and illustrates the diagnostic pitfall in which fat-related imaging findings cause MEST to mimic AMLEC, making the early distinction between MEST and cystic change in fat-containing renal tumors challenging.
- 2 October 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1918612
Open AccessMixed epithelial and stromal tumor of the kidney with prominent peritumoral adipose tissue: a case report radiologically mimicking angiomyolipoma with epithelial cysts
Mixed epithelial and stromal tumor of the kidney (MEST) is a rare renal neoplasm with biphasic differentiation comprising epithelial and stromal components. It typically appears as a mixed cystic-solid mass on imaging, and the prognosis is favorable in the vast majority of cases. We report a case of MEST with a prominent fat component on imaging: a 54-year-old woman was admitted with a 1-month history of left flank distension and pain. Contrast-enhanced computed tomography (CT) showed a mixed cystic-solid mass at the lower pole of the left kidney, with a prominent low-attenuation fat-density area surrounding the mass. Preoperatively, the lesion was considered an unusual angiomyolipoma with epithelial cysts (AMLEC). Because the lesion was small, located at the lower pole, and relatively well circumscribed, the patient underwent laparoscopic left partial nephrectomy. Postoperative histopathologic examination confirmed that the left renal mass was benign; however, immunohistochemistry (IHC) demonstrated positivity for EMA and PCK in the epithelial component and for PR and ER in the stromal component, supporting a diagnosis of MEST. The adipose tissue submitted separately with the tumor was located around the tumor and could not be definitively confirmed as an intratumoral component. This case demonstrates that MEST may also exhibit prominent adipose tissue on imaging and illustrates the diagnostic pitfall in which fat-related imaging findings cause MEST to mimic AMLEC, making the early distinction between MEST and cystic change in fat-containing renal tumors challenging.
- Open Access
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1904049
Decoding the temporal dimension of innate immunity in intravesical BCG therapy
Innate immune signals encode functional instructions through temporal patterns such as oscillation frequency and duration—a principle validated at the single-cell level. Yet clinical evaluation of host responses in tumor immunotherapy remains dominated by “how strongly” the immune system is activated, while the waveform of the response—how it unfolds and when it resolves—is largely overlooked. This disconnect raises unresolved questions: why can tumor progression persist despite intense inflammation, and why is fixed-interval maintenance not universally effective? Intravesical BCG instillation offers a way forward: each instillation is a controlled stimulus, voided urine provides a noninvasive sampling window, and oncological plus bladder-function outcomes form a “controlled stimulus–noninvasive sampling–dual-endpoint” closed loop. Using this model, we propose a hypothesis organized around two observation levels. The fundamental unit is the single−instillation single−cytokine waveform—the complete concentration-time curve of one cytokine following one BCG dose; the second is the longitudinal waveform trajectory, which captures how such waveforms evolve across repeated instillations. Both levels reside at a mesoscopic interface between single-cell signaling dynamics and macro-scale clinical outcomes. Our central hypothesis is that temporal features of a single-instillation single-cytokine waveform—time-to-peak, elimination half-life, and decay morphology—carry predictive information independent of peak amplitude. Distinct waveform shapes may differentially instruct adaptive immune quality, while the decay phase defines the time window for immune homeostasis restoration, thus providing a biological rationale for individualized instillation timing. If validated, this framework would expand the evaluation paradigm for intravesical immunotherapy from an “amplitude” dimension to a dual “amplitude + waveform” paradigm.
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1904049
Open AccessDecoding the temporal dimension of innate immunity in intravesical BCG therapy
Innate immune signals encode functional instructions through temporal patterns such as oscillation frequency and duration—a principle validated at the single-cell level. Yet clinical evaluation of host responses in tumor immunotherapy remains dominated by “how strongly” the immune system is activated, while the waveform of the response—how it unfolds and when it resolves—is largely overlooked. This disconnect raises unresolved questions: why can tumor progression persist despite intense inflammation, and why is fixed-interval maintenance not universally effective? Intravesical BCG instillation offers a way forward: each instillation is a controlled stimulus, voided urine provides a noninvasive sampling window, and oncological plus bladder-function outcomes form a “controlled stimulus–noninvasive sampling–dual-endpoint” closed loop. Using this model, we propose a hypothesis organized around two observation levels. The fundamental unit is the single−instillation single−cytokine waveform—the complete concentration-time curve of one cytokine following one BCG dose; the second is the longitudinal waveform trajectory, which captures how such waveforms evolve across repeated instillations. Both levels reside at a mesoscopic interface between single-cell signaling dynamics and macro-scale clinical outcomes. Our central hypothesis is that temporal features of a single-instillation single-cytokine waveform—time-to-peak, elimination half-life, and decay morphology—carry predictive information independent of peak amplitude. Distinct waveform shapes may differentially instruct adaptive immune quality, while the decay phase defines the time window for immune homeostasis restoration, thus providing a biological rationale for individualized instillation timing. If validated, this framework would expand the evaluation paradigm for intravesical immunotherapy from an “amplitude” dimension to a dual “amplitude + waveform” paradigm.
- Open Access
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 13, 1778536
Prognostic biomarkers and regulatory mechanisms associated with lysine β-hydroxybutyrylation modification in prostate cancer
Background: Prostate cancer (PCa) is a highly prevalent malignant tumor in males. Lysine β-hydroxybutyrylation (Kbhb), an emerging post-translational modification, plays a critical role in tumorigenic processes. However, its functional mechanism in PCa remains elusive. This study aims to identify Kbhb-related prognostic genes in PCa and provide novel insights for its diagnosis, prognosis and treatment. Methods: Candidate genes were obtained through differential expression analysis and intersection analysis. Univariate Cox proportional hazards model and least absolute shrinkage and selection operator (LASSO) regression were employed to screen Kbhb-related prognostic genes, and a risk model was constructed and validated. The expression levels of Kbhb modification and related prognostic genes were validated using Western blotting (WB), real-time quantitative PCR (RT-qPCR) and immunohistochemistry (IHC). Additionally, clinical correlation analysis, nomogram development and validation, immune infiltration analysis, tumor mutation burden (TMB) analysis, gene set enrichment analysis (GSEA), drug sensitivity prediction, molecular regulatory network analysis, drug targeting analysis, and molecular docking were performed. Results: Three genes--kinesin family member 4A (KIF4A), TPX2 microtubule nucleation factor (TPX2), and aurora kinase B (AURKB)—were identified as Kbhb-related prognostic genes. Results of WB indicated that the butyrylation level of the H3K27 (H3K27-Bu) protein was significantly upregulated in PCa tissues. RT-qPCR and IHC results demonstrated that the expression levels of KIF4A, TPX2, and AURKB were significantly higher in the PCa than normal tissues. A risk model based on these genes demonstrated discriminatory ability (AUC >0.6) and served as an independent prognostic factor alongside prostate-specific antigen (PSA). The prognostic nomogram showed high accuracy (AUC 0.82–0.88). High-risk patients exhibited distinct immune infiltration profiles and higher mutation frequencies in tumor protein 53 (TP53), Titin (TTN), and speckle-type POZ protein (SPOP). Drug sensitivity analysis linked the risk score to 24 compounds, while molecular docking suggested that estradiol and bisphenol A could target the identified hub genes. Conclusion: This study identified KIF4A, TPX2, and AURKB as reliable prognostic biomarkers for PCa. These findings provide a theoretical basis for understanding Kbhb-mediated mechanisms in PCa and offer novel targets for early diagnosis and precision therapy.
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 13, 1778536
Open AccessPrognostic biomarkers and regulatory mechanisms associated with lysine β-hydroxybutyrylation modification in prostate cancer
Background: Prostate cancer (PCa) is a highly prevalent malignant tumor in males. Lysine β-hydroxybutyrylation (Kbhb), an emerging post-translational modification, plays a critical role in tumorigenic processes. However, its functional mechanism in PCa remains elusive. This study aims to identify Kbhb-related prognostic genes in PCa and provide novel insights for its diagnosis, prognosis and treatment. Methods: Candidate genes were obtained through differential expression analysis and intersection analysis. Univariate Cox proportional hazards model and least absolute shrinkage and selection operator (LASSO) regression were employed to screen Kbhb-related prognostic genes, and a risk model was constructed and validated. The expression levels of Kbhb modification and related prognostic genes were validated using Western blotting (WB), real-time quantitative PCR (RT-qPCR) and immunohistochemistry (IHC). Additionally, clinical correlation analysis, nomogram development and validation, immune infiltration analysis, tumor mutation burden (TMB) analysis, gene set enrichment analysis (GSEA), drug sensitivity prediction, molecular regulatory network analysis, drug targeting analysis, and molecular docking were performed. Results: Three genes--kinesin family member 4A (KIF4A), TPX2 microtubule nucleation factor (TPX2), and aurora kinase B (AURKB)—were identified as Kbhb-related prognostic genes. Results of WB indicated that the butyrylation level of the H3K27 (H3K27-Bu) protein was significantly upregulated in PCa tissues. RT-qPCR and IHC results demonstrated that the expression levels of KIF4A, TPX2, and AURKB were significantly higher in the PCa than normal tissues. A risk model based on these genes demonstrated discriminatory ability (AUC >0.6) and served as an independent prognostic factor alongside prostate-specific antigen (PSA). The prognostic nomogram showed high accuracy (AUC 0.82–0.88). High-risk patients exhibited distinct immune infiltration profiles and higher mutation frequencies in tumor protein 53 (TP53), Titin (TTN), and speckle-type POZ protein (SPOP). Drug sensitivity analysis linked the risk score to 24 compounds, while molecular docking suggested that estradiol and bisphenol A could target the identified hub genes. Conclusion: This study identified KIF4A, TPX2, and AURKB as reliable prognostic biomarkers for PCa. These findings provide a theoretical basis for understanding Kbhb-mediated mechanisms in PCa and offer novel targets for early diagnosis and precision therapy.
- Open Access
- 12 February 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Application of a Non-Clamping Sutureless Technique Combined with Radiofrequency Ultrasound Scalpel in Laparoscopic Nephron-Sparing Surgery for T1 Renal Cell Carcinoma: A Retrospective Cohort Study
Objective: This study aimed to assess renal cell carcinoma (RCC) complexity using the R.E.N.A.L. nephrometry score and evaluate the feasibility and safety of the non-clamping sutureless technique combined with a radiofrequency ultrasound scalpel (RFUS) for low-complexity RCC. Methods: This retrospective, multi-center cohort study categorized patients into three groups: Group I (suture laparoscopic partial nephrectomy [LPN] with clamping renal artery), Group II (sutureless LPN without renal artery clamping, combined with monopolar electrocoagulation), and Group Ⅲ (sutureless laparoscopic nephron-sparing surgery [LNSS] without renal artery clamping combined with RFUS). Key outcomes included operative time, intraoperative blood loss, postoperative hospital stays, serum creatinine (Scr) levels, and the estimated glomerular filtration rate (eGFR) of the affected kidney. Post hoc power analysis was used to evaluate eGFR variation across groups, and a multiple linear regression model was employed to analyze factors influencing postoperative eGFR alterations. Results: The study included 60 patients with exophytic and low-complexity RCC. Blood loss in Group III was comparable to that in Group I but less than that in Group II ( P = 0.035). Operative time and postoperative hospital stays were significantly shorter in Group III than in the other groups ( P < 0.01). A statistically significant increase in Scr levels was observed during the early postoperative period, continuing through the 6-month follow-up assessment compared with preoperative levels ( P < 0.01). The 6-month postoperative eGFR of the affected kidney in Group III was significantly higher than that in the other groups ( P < 0.01). The decrease in preoperative and 6-month postoperative eGFR values was greatest in Group I ( P < 0.01), followed closely by Group II ( P < 0.01), while no significant reduction was observed in Group III. The post hoc power analysis revealed high detection power (0.912 or 1.0). Warm ischemia time emerged as the sole significant eGFR predictor ( R 2 = 0.814, P < 0.05). Conclusion: The non-clamping sutureless technique combined with RFUS for RCC effectively alleviates renal ischemia–reperfusion injury, offering superior renal function protection while achieving comparable oncological outcomes.
- 12 February 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Open AccessApplication of a Non-Clamping Sutureless Technique Combined with Radiofrequency Ultrasound Scalpel in Laparoscopic Nephron-Sparing Surgery for T1 Renal Cell Carcinoma: A Retrospective Cohort Study
Objective: This study aimed to assess renal cell carcinoma (RCC) complexity using the R.E.N.A.L. nephrometry score and evaluate the feasibility and safety of the non-clamping sutureless technique combined with a radiofrequency ultrasound scalpel (RFUS) for low-complexity RCC. Methods: This retrospective, multi-center cohort study categorized patients into three groups: Group I (suture laparoscopic partial nephrectomy [LPN] with clamping renal artery), Group II (sutureless LPN without renal artery clamping, combined with monopolar electrocoagulation), and Group Ⅲ (sutureless laparoscopic nephron-sparing surgery [LNSS] without renal artery clamping combined with RFUS). Key outcomes included operative time, intraoperative blood loss, postoperative hospital stays, serum creatinine (Scr) levels, and the estimated glomerular filtration rate (eGFR) of the affected kidney. Post hoc power analysis was used to evaluate eGFR variation across groups, and a multiple linear regression model was employed to analyze factors influencing postoperative eGFR alterations. Results: The study included 60 patients with exophytic and low-complexity RCC. Blood loss in Group III was comparable to that in Group I but less than that in Group II ( P = 0.035). Operative time and postoperative hospital stays were significantly shorter in Group III than in the other groups ( P < 0.01). A statistically significant increase in Scr levels was observed during the early postoperative period, continuing through the 6-month follow-up assessment compared with preoperative levels ( P < 0.01). The 6-month postoperative eGFR of the affected kidney in Group III was significantly higher than that in the other groups ( P < 0.01). The decrease in preoperative and 6-month postoperative eGFR values was greatest in Group I ( P < 0.01), followed closely by Group II ( P < 0.01), while no significant reduction was observed in Group III. The post hoc power analysis revealed high detection power (0.912 or 1.0). Warm ischemia time emerged as the sole significant eGFR predictor ( R 2 = 0.814, P < 0.05). Conclusion: The non-clamping sutureless technique combined with RFUS for RCC effectively alleviates renal ischemia–reperfusion injury, offering superior renal function protection while achieving comparable oncological outcomes.
- Open Access
- 31 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (11) , e71118
Solitary Fibrous Tumor of the Renal Hilar in a 52‐Year‐Old Woman: A Case Report
Solitary fibrous tumors (SFTs) are rare spindle cell tumors that primarily originate from the pleura, with infrequent occurrences in the kidney. To date, only a limited number of cases has been reported. This report presents the case of a 52‐year‐old woman diagnosed with an SFTs. Abdominal CT and magnetic resonance imaging revealed a mass lesion in the right kidney, characterized by well‐defined borders and the absence of necrosis or cystic degeneration. Immunohistochemical staining of the tumor tissue demonstrated positive expression of CD34, STAT‐6, and CD99, thereby confirming the diagnosis of SFTs in the right kidney. A laparoscopic radical nephrectomy was performed. A comprehensive literature review was conducted to systematically assess the current understanding of renal SFT. The diagnosis of renal SFTs is established through the synthesis of clinical, pathological, immunohistochemical, and molecular characteristics. Surgery is the treatment of choice. In cases of advanced disease, this is considered the optimal therapeutic approach.
- 31 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (11) , e71118
Open AccessSolitary Fibrous Tumor of the Renal Hilar in a 52‐Year‐Old Woman: A Case Report
Solitary fibrous tumors (SFTs) are rare spindle cell tumors that primarily originate from the pleura, with infrequent occurrences in the kidney. To date, only a limited number of cases has been reported. This report presents the case of a 52‐year‐old woman diagnosed with an SFTs. Abdominal CT and magnetic resonance imaging revealed a mass lesion in the right kidney, characterized by well‐defined borders and the absence of necrosis or cystic degeneration. Immunohistochemical staining of the tumor tissue demonstrated positive expression of CD34, STAT‐6, and CD99, thereby confirming the diagnosis of SFTs in the right kidney. A laparoscopic radical nephrectomy was performed. A comprehensive literature review was conducted to systematically assess the current understanding of renal SFT. The diagnosis of renal SFTs is established through the synthesis of clinical, pathological, immunohistochemical, and molecular characteristics. Surgery is the treatment of choice. In cases of advanced disease, this is considered the optimal therapeutic approach.
- 20 October 2025
- Published by Elsevier in Phytomedicine
- Vol. 148, 157419
Unveiling tectorigenin: A novel ferroptosis inducer targeting EGFR in bladder cancer
- 20 October 2025
- Published by Elsevier in Phytomedicine
- Vol. 148, 157419
Unveiling tectorigenin: A novel ferroptosis inducer targeting EGFR in bladder cancer
- Open Access
- 20 June 2025
- Published by Wolters Kluwer Health in Asian Journal of Andrology
- Vol. 27 (6) , 728-737
Surgical approaches to varicocele: a systematic review and network meta-analysis
Surgical methods for varicocele remain controversial. This study intends to evaluate the efficacy and safety of different surgical approaches for treating varicocele through a network meta-analysis (NMA). PubMed, Embase, Cochrane, and Web of Science databases were thoroughly searched. In total, 13 randomized controlled trials (RCTs) and 24 cohort studies were included, covering 9 different surgical methods. Pairwise meta-analysis and NMA were performed by means of random-effects models, and interventions were ranked based on the surface under the cumulative ranking curve (SUCRA). According to the SUCRA, microsurgical subinguinal varicocelectomy (MSV; 91.6%), microsurgical retroperitoneal varicocelectomy (MRV; 78.2%), and microsurgical inguinal varicocelectomy (MIV; 76.7%) demonstrated the highest effectiveness in reducing postoperative recurrence rates. In this study, sclerotherapy embolization (SE; 87.2%), MSV (77.9%), and MIV (67.7%) showed the best results in lowering the risk of hydrocele occurrence. MIV (82.9%), MSV (75.9%), and coil embolization (CE; 58.7%) were notably effective in increasing sperm motility. Moreover, CE (76.7%), subinguinal approach varicocelectomy (SV; 69.2%), and SE (55.7%) were the most effective in increasing sperm count. SE (82.5%), transabdominal laparoscopic varicocelectomy (TLV; 76.5%), and MRV (52.7%) were superior in shortening the length of hospital stay. The incidence rates of adverse events for MRV (0), SE (3.3%), and MIV (4.1%) were notably low. Cluster analyses indicated that MSV was the most effective in the treatment of varicocele. Based on the existing evidence, MSV may represent the optimal choice for varicocele surgery. However, selecting clinical surgical strategies requires consideration of various factors, including patient needs, surgeon experience, and the learning curve.
- 20 June 2025
- Published by Wolters Kluwer Health in Asian Journal of Andrology
- Vol. 27 (6) , 728-737
Open AccessSurgical approaches to varicocele: a systematic review and network meta-analysis
Surgical methods for varicocele remain controversial. This study intends to evaluate the efficacy and safety of different surgical approaches for treating varicocele through a network meta-analysis (NMA). PubMed, Embase, Cochrane, and Web of Science databases were thoroughly searched. In total, 13 randomized controlled trials (RCTs) and 24 cohort studies were included, covering 9 different surgical methods. Pairwise meta-analysis and NMA were performed by means of random-effects models, and interventions were ranked based on the surface under the cumulative ranking curve (SUCRA). According to the SUCRA, microsurgical subinguinal varicocelectomy (MSV; 91.6%), microsurgical retroperitoneal varicocelectomy (MRV; 78.2%), and microsurgical inguinal varicocelectomy (MIV; 76.7%) demonstrated the highest effectiveness in reducing postoperative recurrence rates. In this study, sclerotherapy embolization (SE; 87.2%), MSV (77.9%), and MIV (67.7%) showed the best results in lowering the risk of hydrocele occurrence. MIV (82.9%), MSV (75.9%), and coil embolization (CE; 58.7%) were notably effective in increasing sperm motility. Moreover, CE (76.7%), subinguinal approach varicocelectomy (SV; 69.2%), and SE (55.7%) were the most effective in increasing sperm count. SE (82.5%), transabdominal laparoscopic varicocelectomy (TLV; 76.5%), and MRV (52.7%) were superior in shortening the length of hospital stay. The incidence rates of adverse events for MRV (0), SE (3.3%), and MIV (4.1%) were notably low. Cluster analyses indicated that MSV was the most effective in the treatment of varicocele. Based on the existing evidence, MSV may represent the optimal choice for varicocele surgery. However, selecting clinical surgical strategies requires consideration of various factors, including patient needs, surgeon experience, and the learning curve.
- Open Access
- 14 April 2025
- Published by Wiley
Solitary fibrous tumor of the renal hilar mass in a 52-year-old woman: a case report
- 14 April 2025
- Published by Wiley
Open AccessSolitary fibrous tumor of the renal hilar mass in a 52-year-old woman: a case report